Please login to the form below

Not currently logged in
Email:
Password:

Reig Jofre

This page shows the latest Reig Jofre news and features for those working in and with pharma, biotech and healthcare.

Reig Jofre and LeanBio launch Syna Therapeutics

Reig Jofre and LeanBio launch Syna Therapeutics

Reig Jofre and LeanBio launch Syna Therapeutics. The new company will focus on the development of biosimilars. ... Pharmaceutical group Reig Jofre has entered into a strategic alliance with LeanBio, a four-year-old biotech company, to launch a new

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Reig Jofre boosts Forté Pharma’s senior team Reig Jofre boosts Forté Pharma’s senior team

    Reig Jofre boosts Forté Pharma’ s senior team. Appoints Alain Boutboul as the nutritional supplements group’s general manager. ... Reig Jofre’s nutritional supplement group Forté Pharma has appointed a new general manager in the form of Alain

  • Reig Jofre appoints Alejandro Reig as vice president Reig Jofre appoints Alejandro Reig as vice president

    Reig Jofre appoints Alejandro Reig as vice president. He previously served as director of the company. ... Spanish pharmaceutical group Reig Jofre has appointed Alejandro Reig as its new vice president.

  • Reig Jofre bolsters its senior team Reig Jofre bolsters its senior team

    Reig Jofre bolsters its senior team. Gabriel Roig and Roser Gomila join as COO and CFO, respectively. ... Spanish pharmaceutical group Reig Jofre has promoted Gabriel Zapatero (pictured right) to chief operating officer (COO) from his previous role as

More from appointments
Approximately 3 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics